MACROPLASTIQUE IMPLANTS MPQ-2.5

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2018-03-09 for MACROPLASTIQUE IMPLANTS MPQ-2.5 manufactured by Uroplasty, Llc.

Event Text Entries

[102207221] The issue was discovered through a routine literature search. Several attempts were made to reach the author for more information regarding the event, however no response was received. It was noted that the patient received several repeat treatments with mpq despite limited improvement in her symptoms. This, coupled with the patient's history, may indicate that she was a poor candidate for treatment.
Patient Sequence No: 1, Text Type: N, H10


[102207222] A (b)(6) year-old caucasian female first presented 20 years ago with bladder prolapse and genuine stress urinary incontinence (sui). After failing to improve on conservative management and colposuspension, she underwent a macroplastique (mpq) injection for persistent urodynamically confirmed sui. She experienced brief symptomatic improvement, but symptoms reoccurred within months, leading to three separate injections of mpq at six monthly intervals. Each of these injections had a similar outcome as previously, but after the final injection, her symptoms partially settled, but she experienced storage systems. Seven years ago, these storage systems worsened. A cystoscopy performed showed mucosal swellings with calcifications close to the bladder neck and the proximal urethra. The calcifications were resected, and histopathology showed foreign material without malignancy. The patient's sui did not deteriorate any further, however she developed urgency symptoms. Two years ago, patient was referred for non-visible haematuria with post-micturition pain. A cystoscopy revealed unhealthy areas close to the bladder neck that were resected. Histopathology showed only a foreign body reaction, and an ultrasound showed echogenic material in the bladder wall close to the bladder neck.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number3002647932-2018-00003
MDR Report Key7328022
Date Received2018-03-09
Date of Report2018-03-09
Date Mfgr Received2017-11-16
Date Added to Maude2018-03-09
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMS. NICOLE BOSER
Manufacturer Street5420 FELTL ROAD
Manufacturer CityMINNETONKA MN 55343
Manufacturer CountryUS
Manufacturer Postal55343
Manufacturer Phone9524266141
Manufacturer G1UROPLASTY, LLC
Manufacturer Street5420 FELTL ROAD
Manufacturer CityMINNETONKA MN 55343
Manufacturer CountryUS
Manufacturer Postal Code55343
Single Use3
Previous Use Code3
Event Type3
Type of Report0

Device Details

Brand NameMACROPLASTIQUE IMPLANTS
Generic NameURETHERAL BULKING AGENT
Product CodeLNM
Date Received2018-03-09
Model NumberMPQ-2.5
Catalog NumberMPQ-2.5
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerUROPLASTY, LLC
Manufacturer Address5420 FELTL ROAD MINNETONKA MN 55343 US 55343


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2018-03-09

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.